Parkinson’s Disease Case 2

72-year-old male diagnosed with Parkinson’s disease in the early stages. His history includes 23 years of occupational exposure to lead and radiation while handling copper and fiber optic cables. He retired in 2022 due to symptom onset and has since reported unintentional weight loss of 20 lbs over 6 months, though he remains physically active with regular treadmill exercise.

He underwent IV stem cell therapy with umbilical cord-derived Stem Cells (50 million native non-expanded) combined with exosomes. Following treatment, he reported improved sleep, clearer and more fluent speech which was noted by friends, increased physical stamina, and enhanced mood stability with better mental and emotional well-being.

The patient also began adjunctive therapy utitlizing Cerebrolysin, receiving two cycles of treatment, he described sharper overall cognition, improved verbal communication, less slurring, enhanced clarity of thought, and greater energy and mental focus. Friends and family have also observed noticeable improvements in his speech and cognitive performance.